Table II.
Discontinued participants, n | Mild to moderate adverse events, n/total n | Serious adverse events n/total n | ||||
---|---|---|---|---|---|---|
First author, year (ref.) | Experimental | Control | Experimental | Control | Experimental | Control |
Idan et al, 2010 (15) | 19 | 14 | 13/55 | 5/55 | 8/55 | 11/55 |
Ho et al, 2012 (21) | 4 | 2 | 3/60 | 1/60 | 1/60 | 1/60 |
Kaufman et al, 2011 (18) | 66 | 12 | 134/234 | 15/40 | 5/234 | 1/40 |
Emmelot-Vonk et al, 2008 (7) | 16 | 14 | 104/113 | 105/110 | 5/113 | 10/110 |
Srinivas-Shankar et al, 2010 (17) | 15 | 16 | 10/130 | 7/132 | 6/130 | 3/132 |
Behre et al, 2012 (6) | 15 | 24 | 12/183 | 10/179 | 7/183 | 6/179 |